TWI369991B - Use of clostridium perfringens type c bacterium for the manufacture of a vaccine - Google Patents

Use of clostridium perfringens type c bacterium for the manufacture of a vaccine

Info

Publication number
TWI369991B
TWI369991B TW096140460A TW96140460A TWI369991B TW I369991 B TWI369991 B TW I369991B TW 096140460 A TW096140460 A TW 096140460A TW 96140460 A TW96140460 A TW 96140460A TW I369991 B TWI369991 B TW I369991B
Authority
TW
Taiwan
Prior art keywords
vaccine
bacterium
clostridium perfringens
manufacture
perfringens type
Prior art date
Application number
TW096140460A
Other languages
Chinese (zh)
Other versions
TW200831121A (en
Inventor
Maarten Hendrik Witvliet
Jozef Franciscus Maria Smeets
Keith Redhead
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of TW200831121A publication Critical patent/TW200831121A/en
Application granted granted Critical
Publication of TWI369991B publication Critical patent/TWI369991B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to the use of a vaccine comprising Clostridium perfringens type C bacterium for protecting swine against Clostridium perfringens type A infection.
TW096140460A 2006-11-20 2007-10-26 Use of clostridium perfringens type c bacterium for the manufacture of a vaccine TWI369991B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86044706P 2006-11-20 2006-11-20
EP06124404 2006-11-20

Publications (2)

Publication Number Publication Date
TW200831121A TW200831121A (en) 2008-08-01
TWI369991B true TWI369991B (en) 2012-08-11

Family

ID=38535530

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096140460A TWI369991B (en) 2006-11-20 2007-10-26 Use of clostridium perfringens type c bacterium for the manufacture of a vaccine

Country Status (8)

Country Link
CN (1) CN101541343B (en)
AT (1) ATE540692T1 (en)
BR (1) BRPI0718639A2 (en)
DK (1) DK2086578T3 (en)
ES (1) ES2380134T3 (en)
RU (1) RU2462263C2 (en)
TW (1) TWI369991B (en)
UA (1) UA95652C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688484B (en) * 2012-06-13 2016-03-30 北京中海生物科技有限公司 A kind of production method of chicken necrotizing enterocolitis (C type) inactivated vaccine
CN107789622A (en) * 2017-10-18 2018-03-13 山东农业大学 A kind of calf enterotoxemia C.perfringens β2The preparation method of toxin toxoid vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2129441C1 (en) * 1997-12-10 1999-04-27 Пирожков Михаил Константинович Mixed vaccine against anaerobic enterotoxemia and escherichiosis in piglets
UA65816A (en) * 2003-05-30 2004-04-15 Vasyl Petrovych Ryzhenko Vaccine velshisan for preventing toxicoinfections caused by clostridium perfringens

Also Published As

Publication number Publication date
DK2086578T3 (en) 2012-05-14
CN101541343B (en) 2012-05-16
TW200831121A (en) 2008-08-01
UA95652C2 (en) 2011-08-25
ATE540692T1 (en) 2012-01-15
CN101541343A (en) 2009-09-23
BRPI0718639A2 (en) 2013-11-26
ES2380134T3 (en) 2012-05-08
RU2009123478A (en) 2010-12-27
RU2462263C2 (en) 2012-09-27

Similar Documents

Publication Publication Date Title
BR112012014082A2 (en) compositions and methods comprising protease variants
MX2012007098A (en) Phenol derivatives and pharmaceutical or cosmetic use thereof.
IN2012DN00829A (en)
MY153915A (en) Organic compounds
MX2012007161A (en) Phenol derivatives and pharmaceutical or cosmetic use thereof.
UA106748C2 (en) Proline derivatives as cathepsin inhibitors
MX2012007507A (en) Heteroaryl compounds and uses thereof.
MX2012004780A (en) Akt inhibitors.
MX2009013354A (en) Tri-aryl compounds and compositions comprising the same.
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
MX2009005938A (en) 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases.
MX2010004487A (en) Therapeutic substituted lactams.
AU2010280497A8 (en) Anhydrate of tiotropium bromide
UA107592C2 (en) COMPOSITION FOR CONTROLLING PLANT DISEASES AND ITS APPLICATION
MX2009005117A (en) Use of clostridium perfringens type c bacterium for the manufacture of a vaccine.
MX2009001578A (en) Therapeutic lactams.
TWI369991B (en) Use of clostridium perfringens type c bacterium for the manufacture of a vaccine
MX349563B (en) Pharmaceutical formulation of nanonised fenofibrate.
UA96476C2 (en) Pharmaceutical composition comprising irbesartan
MX2009007929A (en) Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen.
ATE551036T1 (en) CONDOM PACKAGING
HK1131156A1 (en) Novel morphine derivatives
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2012007097A (en) Phenol derivatives and the pharmaceutical or cosmetic use thereof.
MX2011011180A (en) Compounds having a physiological effect.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees